Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE

Journal of Neurochemistry

Volumn 98, Issue 6, 2006, Pages 1817-1827

  Wang, Chunhe ^a,b   Gold, Bruce G ^b   Kaler, Laurie J ^a   Yu, Xiaolin ^b   Afentoulis, Michael E ^a   Burrows, Gregory G ^b,c   Vandenbark, Arthur A ^a,b,c   Bourdette, Dennis N ^a,b   Offner, Halina ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Axonal loss; Demyelination; Multiple sclerosis; T lymphocytes

Indexed keywords

ENCEPHALITOGENIC PROTEIN; MYELIN; RECOMBINANT PROTEIN; RECOMBINANT T LYMPHOCYTE RECEPTOR LIGAND; RTL 401; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMYELINATION; ELECTRON MICROSCOPY; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; T LYMPHOCYTE;

ANIMALIA;

EID: 33748129891     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04081.x     Document Type: Article

References (35)

1. Arnold D. L., Matthews P. M., Francis G. S., O'Connor J. and Antel J. P. (1992) Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31, 235-241.
2. Back S. A., Tuohy T. M., Chen H., Wallingford N., Craig A., Struve J., Luo N. L., Banine F., Liu Y., Chang A., Trapp B. D., Bebo B. F. Jr, Rao M. S. and Sherman L. S. (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med. 11, 966-972.
3. Barkhof F., Bruck W., De Groot C. J., Bergers E., Hulshof S., Geurts J., van Polman C. H. and d V. (2003) Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch. Neurol. 60, 1073-1081.
4. Bruck W. (2005) The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol. 252, v3-v9.
5. Burrows G. G., Adlard K. L., Bebo B. F. Jr, Chang J. W., Tenditnyy K., Vandenbark A. A. and Offner H. (2000) Regulation of encephalitogenic T cells with recombinant TCR ligands. J. Immunol. 164, 6366-6371.
6. Burrows G. G., Chou Y. K., Wang C., Chang J. W., Finn T. P., Culbertson N. E., Kim J., Bourdette D. N., Lewinsohn D. A., Lewinsohn D. M., Ikeda M., Yoshioka T., Allen C. N., Offner H. and Vandenbark A. A. (2001) Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J. Immunol. 167, 4386-4395.
7. Chang J. W., Mechling D. E., Bachinger H. P. and Burrows G. G. (2001) Design, engineering, and production of human recombinant T cell receptor ligands derived from human leukocyte antigen DR2. J. Biol. Chem. 276, 24 170-24 176.
8. D'Souza S., Alinauskas K., McCrea E., Goodyer C. and Antel J. P. (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15, 7293-7300.
9. Fassas A., Passweg J. R., Anagnostopoulos A et al. (2002) Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J. Neurol. 249, 1088-1097.
10. Ferguson B., Matyszak M. K., Esiri M. M. and Perry V. H. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399.
11. Fu L., Matthews P. M., De Stefano N., Worsley K. J., Narayanan S., Francis G. S., Antel J. P., Wolfson C. and Arnold D. L. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121, 103-113.
12. Gold B. G., Voda J., Yu X., Mckeon G. and Bourdette D. N. (2004) FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis. J. Neurosci. Res. 77, 367-377.
13. Grados-Munro E. M. and Fournier A. E. (2003) Myelin-associated inhibitors of axon regeneration. J. Neurosci. Res. 74, 479-485.
14. Huan J., Subramanian S., Jones R., Rich C., Link J., Mooney J., Bourdette D. N., Vandenbark A. A., Burrows G. G. and Offner H. (2004) Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch. J. Immunol. 172, 4556-4566.
15. Inglese M., Mancardi G. L., Pagani E., Rocca M. A., Murialdo A., Saccardi R., Comi G. and Filippi M. (2004) Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J. Neurol. Neurosurg Psychiatry 75, 643-644.
16. Kerschensteiner M., Stadelmann C., Dechant G., Wekerle H. and Hohlfeld R. (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann. Neurol. 53, 292-304.
17. Kondo Y., Wenger D. A., Gallo V. and Duncan I. D. (2005) Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc. Natl Acad. Sci. USA 102, 18 670-18 675.
18. Koprivica V., Cho K. S., Park J. B., Yiu G., Atwal J., Gore B., Kim J. A., Lin E., Tessier-Lavigne M., Chen D. F. and He Z. (2005) EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310, 106-110.
19. Link J. M., Rich C. M., Korat M., Burrows G. G., Offner H. and Vandenbark A. A. (2006) Preclinical studies demonstrate rapid and potent modulation of experimental encephalomyelitis in humanized DR2+ transgenic mice treated with a soluble recombinant TCR ligand containing DR2/MOG-35-55 peptide. Clin. Immunol., submitted.
20. Lublin F. (2005) Multiple sclerosis trial designs for the 21 (st) century: Building on recent lessons. J. Neurol. 252:: v46-v53.
21. Mancardi G. L., Saccardi R., Filippi M. et al. (2001) Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57, 62-68.
22. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I. R. and Schwartz M. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 5, 49-55.
23. Nitsch R., Pohl E. E., Smorodchenko A., Infante-Duarte C., Aktas O. and Zipp F. (2004) Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. J. Neurosci. 24, 2458-2464.
24. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A. A., Huan J. and Burrows G. G. (2005) Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 175, 4103-4111.
25. Papadopoulos D., Pham-Dinh D. and Reynolds R. (2006) Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol. 197, 373-385.
26. Pitt D., Werner P. and Raine C. S. (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med. 6, 67-70.
27. Rammohan K. W. (2003) Axonal injury in multiple sclerosis. Curr. Neurol. Neurosci. Rep 3, 231-237.
28. Rieckmann P. and Smith K. J. (2001) Multiple sclerosis: more than inflammation and demyelination. Trends Neurosci. 24, 435-437.
29. Schwartz M. and Kipnis J. (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J. Neurol. Sci. 233, 163-166.
30. Steinman L. (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302.
31. Szelényi J. (2001) Cytokines and the central nervous system. Brain Res. Bull. 54, 329-338.
32. Trapp B. D., Peterson J., Ransohoff R. M., Rudick R., Mork S. and Bo L. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl. J. Med. 338, 278-285.
33. Vandenbark A. A., Rich C., Mooney J., Zamora A., Wang C., Huan J., Fugger L., Offner H., Jones R. and Burrows G. G. (2003) Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. J. Immunol. 171, 127-133.
34. Wang C., Mooney J. L., Meza-Romero R., Chou Y. K., Huan J., Vandenbark A. A., Offner H. and Burrows G. G. (2003) Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation. J. Immunol. 171, 1934-1940.
35. Waxman S. G. (1998) Demyelinating diseases - new pathological insights, new therapeutic targets. N Engl. J. Med. 338, 323-325.